179 related articles for article (PubMed ID: 30101434)
1. Detection of hypermethylated genes as markers for cervical screening in women living with HIV.
Kremer WW; Van Zummeren M; Novianti PW; Richter KL; Verlaat W; Snijders PJ; Heideman DA; Steenbergen RD; Dreyer G; Meijer CJ
J Int AIDS Soc; 2018 Aug; 21(8):e25165. PubMed ID: 30101434
[TBL] [Abstract][Full Text] [Related]
2. Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort.
Verhoef L; Bleeker MCG; Polman N; Steenbergen RDM; Meijer CJLM; Melchers WJG; Bekkers RL; Molijn AC; Quint WG; van Kemenade FJ; Berkhof J; Heideman DAM
Int J Cancer; 2022 Feb; 150(3):440-449. PubMed ID: 34558659
[TBL] [Abstract][Full Text] [Related]
3. HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.
Kremer WW; van Zummeren M; Heideman DAM; Lissenberg-Witte BI; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360578
[TBL] [Abstract][Full Text] [Related]
4. Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus.
Vink FJ; Meijer CJLM; Lissenberg-Witte BI; Visser C; Duin S; Snyman LC; Richter KL; van der Merwe FH; Botha MH; Steenbergen RDM; Dreyer G
Clin Infect Dis; 2023 Feb; 76(3):416-423. PubMed ID: 36366827
[TBL] [Abstract][Full Text] [Related]
5. Posttreatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3.
Vink FJ; Steenbergen RDM; Kremer WW; Lissenberg-Witte BI; Heideman DAM; Bleeker MCG; van Zummeren M; Breytenbach E; Visser C; Lukhwareni A; Meijer CJLM; Dreyer G
AIDS; 2022 Jun; 36(7):953-961. PubMed ID: 35152224
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of six methylation markers derived from genome-wide screens for detection of cervical precancer and cancer.
Dick S; Verhoef L; De Strooper LM; Ciocănea-Teodorescu I; Wisman GBA; Meijer CJ; Bleeker MC; Steenbergen RD; Heideman DA
Epigenomics; 2020 Sep; 12(18):1569-1578. PubMed ID: 32938193
[No Abstract] [Full Text] [Related]
7. Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme.
de Waard J; Bhattacharya A; de Boer MT; van Hemel BM; Esajas MD; Vermeulen KM; de Bock GH; Schuuring E; Wisman GBA
Clin Epigenetics; 2023 Jun; 15(1):103. PubMed ID: 37322534
[TBL] [Abstract][Full Text] [Related]
8. The use of molecular markers for cervical screening of women living with HIV in South Africa.
Kremer WW; van Zummeren M; Breytenbach E; Richter KL; Steenbergen RDM; Meijer CJLM; Dreyer G
AIDS; 2019 Nov; 33(13):2035-2042. PubMed ID: 31385866
[TBL] [Abstract][Full Text] [Related]
9. Methylation testing for the detection of recurrent cervical intraepithelial neoplasia.
Dick S; Heideman DAM; Mom CH; Meijer CJLM; Berkhof J; Steenbergen RDM; Bleeker MCG
Int J Cancer; 2023 Dec; 153(12):2011-2018. PubMed ID: 37539971
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
Verhoef L; Bleeker MCG; Polman N; Steenbergen RDM; Ebisch RMF; Melchers WJG; Bekkers RLM; Molijn AC; Quint WG; van Kemenade F; Meijer CJLM; Berkhof J; Heideman DAM
Br J Cancer; 2023 Jul; 129(1):104-111. PubMed ID: 37100874
[TBL] [Abstract][Full Text] [Related]
11. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
[TBL] [Abstract][Full Text] [Related]
12. Selection of women at risk for cervical cancer in an HIV-infected South African population.
Van Zummeren M; Kremer WW; Van Aardt MC; Breytenbach E; Richter KL; Rozendaal L; Witte BI; De Strooper LMA; Hesselink AT; Heideman DAM; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
AIDS; 2017 Sep; 31(14):1945-1953. PubMed ID: 28692545
[TBL] [Abstract][Full Text] [Related]
13. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection.
van den Helder R; Steenbergen RDM; van Splunter AP; Mom CH; Tjiong MY; Martin I; Rosier-van Dunné FMF; van der Avoort IAM; Bleeker MCG; van Trommel NE
Clin Cancer Res; 2022 May; 28(10):2061-2068. PubMed ID: 35266975
[TBL] [Abstract][Full Text] [Related]
14. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.
Verlaat W; Snoek BC; Heideman DAM; Wilting SM; Snijders PJF; Novianti PW; van Splunter AP; Peeters CFW; van Trommel NE; Massuger LFAG; Bekkers RLM; Melchers WJG; van Kemenade FJ; Berkhof J; van de Wiel MA; Meijer CJLM; Steenbergen RDM
Clin Cancer Res; 2018 Jul; 24(14):3456-3464. PubMed ID: 29632006
[No Abstract] [Full Text] [Related]
18. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
[TBL] [Abstract][Full Text] [Related]
19. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
